Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis

Shinji Noda1, Yoshihide Asano1, Satoshi Nishimura2

  • 1Department of Dermatology, the University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Nature Communications
|December 16, 2014
PubMed

Insights

Epigenetic suppression of Friend leukaemia integration 1 (Fli1) and Krüppel-like factor 5 (KLF5) drives systemic sclerosis (SSc). Mice lacking these factors develop SSc hallmarks, revealing a unifying pathogenic mechanism.

Area of Science:

  • Immunology
  • Genetics
  • Dermatology

Background:

  • Systemic sclerosis (SSc) presents with fibrosis, vasculopathy, and immune dysregulation, lacking a unifying pathogenic hypothesis.
  • The multifactorial nature of SSc involves genetic and environmental factors.
  • Epigenetic suppression of transcription factors Friend leukaemia integration 1 (Fli1) and Krüppel-like factor 5 (KLF5) occurs in SSc dermal fibroblasts.

Purpose of the Study:

  • To investigate the role of Fli1 and KLF5 epigenetic downregulation in SSc pathogenesis.
  • To explore the combined effect of Fli1 and KLF5 suppression on fibrotic markers.
  • To determine if mimicking the epigenetic phenotype in mice recapitulates SSc features.

Main Methods:

  • Investigated Fli1 and KLF5 expression in SSc dermal fibroblasts.
  • Performed simultaneous knockdown of Fli1 and KLF5 to assess connective tissue growth factor (CTGF) expression.
  • Generated and analyzed mice with double heterozygous deficiency of Klf5 and Fli1.

Main Results:

  • Fli1 silencing alone induced collagen production.
  • Simultaneous Fli1 and KLF5 knockdown synergistically enhanced CTGF expression.
  • Mice with double heterozygous deficiency of Klf5 and Fli1 spontaneously developed SSc features: skin and lung fibrosis, vasculopathy, B-cell activation, and autoantibody production.

Conclusions:

  • Epigenetic downregulation of Fli1 and KLF5 is implicated as a central event in SSc.
  • This downregulation triggers the pathogenic triad of fibrosis, vasculopathy, and immune dysregulation in SSc.
  • The findings provide a unifying hypothesis for SSc pathogenesis.